|
1.
|
Sternberg CN, Yagoda A, Scher HI, et al:
Preliminary results of M-VAC (methotrexate, vinblastine,
doxorubicin and cisplatin) for transitional cell carcinoma of the
urothelium. J Urol. 133:403–407. 1985.PubMed/NCBI
|
|
2.
|
Masse HM, Hansen SW, Robert JT, et al:
Gemcitabine and cisplatin versus methotrexate, vinblastine,
doxorubicin and cisplatin in advanced or metastatic bladder cancer;
results of a large, randomized, multinational, multicancer, phase
III study. J Clin Oncol. 18:3068–3077. 2000.
|
|
3.
|
Saxman SB, Propert KJ, Einborn LH, et al:
Long-term follow-up of a phase III intergroup study of cisplatin
alone or in combination with methotrexate, vinblastine and
doxorubicin in patients with metastatic urothelial carcinoma; a
cooperative group study. J Clin Oncol. 15:2564–2569.
1997.PubMed/NCBI
|
|
4.
|
Sternberg CN, Yagoda A, Scher HI, et al:
Methotrexate, vinblastine, doxorubicin and cisplatin for advanced
transitional cell carcinoma of the urothelium. Efficacy and
patterns of response and relapse. Cancer. 64:2448–2458. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Mizuno S: Biological and medical grounds
of combination with hyperthermia and radiotherapy. Hyperthermia
Manual (in Japanese). Matsuda T: Magupuros Publication Co.; pp.
1–5. 1991
|
|
6.
|
Mitsuhashi N: Positioning in combination
therapy and future subjects. Hyperthermia – Guide Book of
Hyperthermia for Cancer Therapy (in Japanese). Japanese Society for
Thermal Medicine, Mainichi-kenkousaron Publication Co.; pp. 6–7.
2008
|
|
7.
|
Itoh Y, Kazaoka Y, Nitta M, et al:
Combining anti-tumor drugs with mild hyperthermia increases the
cytotoxic effects of drugs on human leukemia cells in vitro.
Mol Med Rep. 2:411–415. 2009.PubMed/NCBI
|
|
8.
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Zwelling LA and Kohn KW: Mechanism of
action of cis-dichlorodiammineplatinum (II). Cancer Treat Rep.
63:1439–1444. 1979.PubMed/NCBI
|
|
10.
|
Di M: Adriamycin (NSC-123127): mode and
mechanism of action. Cancer Chemother Rep. 6:91–106. 1975.
|
|
11.
|
Nemoto T and Takahira H: Uptake of
adriamycin into the cells and the interaction with DNA.
Yakugakuzasshi (in Japanese). 93:1498–1508. 1973.
|
|
12.
|
Kameda K, Kondo T, Tanabe K, et al: The
role of intracellular Ca2+ in apoptosis induced by
hyperthermia and its enhancement by verapamil in U937 cells. Int J
Radiat Oncol. 49:1369–1379. 2001.PubMed/NCBI
|
|
13.
|
Hall EJ and Roizin T: Biological effects
of heat. Cancer Res. 44:S4708–S4713. 1984.
|
|
14.
|
Shioura H, Hayashi S, Matsumoto H, et al:
The effects of combined treatments with low hyperthermia and
bleomycin on survival of murine L cells. Clin Cancer Res.
16:147–152. 1997.PubMed/NCBI
|
|
15.
|
Kano E, Furukawa-Furuya M and Nitta K:
Sensitivity of bleomycin-resistant variant cells enhanced by 40°C
hyperthermia in vitro. Int J Hyperthermia. 4:5547–5553.
1988.PubMed/NCBI
|
|
16.
|
Ono H, Ando S and Suzuki T: The drug
uptake in the tumor with the mild-hyperthermia treatment in
combination with the chemotherapy in vivo. Jpn J Hyperthermic
Oncol. 22:23–33. 2006. View Article : Google Scholar
|
|
17.
|
Huang Q, Hu JK and Lohr F: Heat-induced
gene expression as a novel targeted cancer gene therapy strategy.
Cancer Res. 60:3435–3439. 2000.PubMed/NCBI
|
|
18.
|
Urano M, Kuroda M and Nishimura Y: For the
clinical application of thermal chemotherapy given at mild
temperatures. Int J Hyperthermia. 15:79–107. 1999. View Article : Google Scholar
|
|
19.
|
Ahmed K, Hori T and Yu DA: Hyperthermia
chemo-sensitization, chemical thermo-sensitization and apoptosis.
Thermal Med. 24:1–12. 2008. View Article : Google Scholar
|
|
20.
|
Itoh Y, Tazawa K, Wada K, et al: Induction
of HSP 70 in lymphocytes by whole body far-infrared hyperthermia.
Jpn J Hyperthermic Oncol. 21:209–220. 2005.
|
|
21.
|
Itoh Y, Ogawa K and Tazawa K: Improvement
of athletic performances by heat shock protein 70 induced with mild
hyperthermia. Jpn J Clin Physiol. 38:13–21. 2008.
|
|
22.
|
Itoh Y and Yamada Y: Enhancement of the
anti-tumor effects and improvement of QOL by the combination with
mild hyperthermia. In: 67th Annual Meeting of the Japanese Cancer
Association (JCA 2008) – Proceedings; pp. 3612008
|
|
23.
|
Yamada Y, Itoh Y and Honda Y: Increase of
anti-tumor effect by combination therapy with mild hyperthermia and
chemotherapy for bladder cancer. Thermal Med (in Japanese).
24:S652008.
|
|
24.
|
Yamada Y, Itoh Y, Aoki S, et al:
Preliminary results of M-VAC chemotherapy combined with mild
hyperthermia, a new therapeutic strategy for advanced or metastatic
transitional cell carcinoma of the urothelium. Cancer Chemother
Pharmacol. 64:1079–1083. 2009. View Article : Google Scholar : PubMed/NCBI
|
